Endothelial and fibroblastic activation in scleroderma: The myth of the “uninvolved skin”
✍ Scribed by Henry N. Claman; Ralph C. Giorno; James R. Seibold
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 736 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
✦ Synopsis
We studied the immunohistochemistry of the skin Of scleroderma patients to determine the differences (if any) between clinically "affected" and "nonaffected" areas. We examined paired skin biopsy samples from clinically involved forearm skin ("affected") and clinically uninvolved proximal skin ("nonaffected") taken from 19 patients with diffuse scleroderma and from 15 normal control subjects. We stained the sections with antibodies to endothelial leukocyte-adherence molecule type 1 (ELAM-1; to detect endothelial activation) and to procollagen.1 (PC-1; to detect newly formed, unprocessed collagen). There was increased expression Of ELAM-1 and PC-1 in sclerodermatous skin as compared with the controls, but there was no difference between From the
📜 SIMILAR VOLUMES
## Abstract ## Objective To determine whether biopsy specimens obtained from systemic sclerosis (SSc) lesions show a distinctive gene profile, whether that gene profile is maintained in fibroblasts cultured from SSc skin biopsy specimens, and whether results from tissue obtained from multiple clin